Immunic Common Stock Shares Outstanding from 2010 to 2025
| IMUX Stock | USD 0.70 0.01 1.99% |
Common Stock Shares Outstanding | First Reported 2012-09-30 | Previous Quarter 132.2 M | Current Value 193.9 M | Quarterly Volatility 40.5 M |
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 127.3 K, Interest Expense of 730.2 K or Other Operating Expenses of 61.2 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 5.71. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
Immunic | Common Stock Shares Outstanding | Build AI portfolio with Immunic Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immunic Stock Analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.